Next Article in Journal
Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?
Next Article in Special Issue
Oxidative Stress Induced Mitochondrial Failure and Vascular Hypoperfusion as a Key Initiator for the Development of Alzheimer Disease
Previous Article in Journal / Special Issue
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
Pharmaceuticals 2009, 2(3), 287-298; doi:10.3390/ph2030287

Notes on Article Versions

NoteDate
article html file updated18 January 2013 01:09 CET
article html file updated21 January 2013 18:59 CET
article html file updated25 January 2013 20:35 CET
article html file updated28 January 2013 18:01 CET
article html file updated5 February 2013 20:23 CET
article html file updated6 February 2013 16:15 CET
article xml file uploaded28 April 2014 10:59 CEST
article html file updated28 April 2014 10:59 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert